LGR5 and colorectal carcinoma: In addition, in the 2011 phase 1 clinical trial studying the effects of BRB slurry in CRC patients, it was reported that patients showed differential response to the BRB intervention, which was in part related to the length of time that patients were on the BRB treatment.[6] This may account for our observed patient variation in colonic LGR5 expression.